
July 29, 2024
Positive results from the initial, prospective ADHD clinical trial run by BlinkLab and MCG provides a strong foundation for clinical adoption.
BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered neurometric tests to aid in the diagnosis of neurodevelopmental conditions, is pleased to announce a major research and clinical partnership with Mental Care Group (MCG) in The Netherlands.
Highlights
- Strategic partnership with the fifth largest outpatient mental health care provider in Europe.
- Partnership formalised following successful outcomes of a pilot study led by Mental Care Group that validated Blinklab’s technology in a clinical setting.
- Initial prospective study in 184 participants showed that children with ADHD have significantly heightened sensory sensitivity, which can be objectively quantified by measuring the rate and amplitude of sound-evoked eyelid responses using the BlinkLab app.
- Partnership will accelerate BlinkLab’s path to European and US regulatory approval for ADHD and clinical adoption. Data collected from the current clinical trial will be used as part of a large global ADHD study conducted by BlinkLab.
- Blinklab and MCG will scale up the rollout and validation of the solution in the coming years to a broader patient group and additional diagnosis.
Smartphone-based digital sensory phenotyping is emerging as a promising aid in the diagnosis of ADHD. BlinkLab has developed an innovative app that administers these tests, using the smartphone’s sensors to capture precise neurometric data. As part of the agreement MCG is anticipating to integrate the BlinkLab app into their processes for ADHD diagnosis. By analysing the nuanced behavioural and physiological responses collected via the app, BlinkLab will aim to identify ADHD characteristics, potentially offering patients a more rapid, accessible and objective assessment method. Through this partnership, MCG will use BlinkLab’s technology to enhance their diagnostic accuracy and efficiency. This collaboration between BlinkLab and MCG exemplifies the potential of our mobile health platform to advance mental health diagnostics worldwide.
About Mental Care Group
Mental Care Group is the largest outpatient mental health care provider in the Netherlands and fifth largest in Europe. With 150 locations it includes a national network of psychologists, psychotherapists and psychiatrists serving over 80,000 patients annually. Leveraging its extensive knowledge and experience in Dutch mental healthcare, MCG focuses on all aged groups. The care offered includes treatments for anxiety disorders, depressive complaints, post-traumatic stress disorders (PTSD), ADHD and autism.
As a pioneer in e-health, MCG provides patients with multiple digital applications, including online enrolment, intake, and an extensive e-health library. Additionally, a segment of their patient base benefits from online or blended treatments. In partnership with BlinkLab, MCG envisions a transformative future where medical technology, AI, and digital applications revolutionize the prediction, diagnosis, and early intervention of healthcare needs. An example of the innovation is the patient portal that MCG developed in-house and went online this week. This collaboration aims to offer innovative treatment and support methods, enhancing patient outcomes and setting new standards in mental healthcare.
European Regulatory Approval and Clinical Adoption
BlinkLab and MCG will work together to obtain regulatory approval for the diagnostic application, and to accelerate the path to clinical adoption and reimbursement. The current study conducted in the Netherlands potentially could be used as part of the global ADHD study with BlinkLab opening additional recruitment and testing.
Click here for the full ASX Release
This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
BB1:AU
The Conversation (0)
01 May
Successful Placement of A$7.66M to Underpin Growth Strategy
BlinkLab Limited (BB1:AU) has announced Successful Placement of A$7.66M to Underpin Growth StrategyDownload the PDF here. Keep Reading...
29 April
Trading Halt
BlinkLab Limited (BB1:AU) has announced Trading HaltDownload the PDF here. Keep Reading...
27 April
Quarterly Activities/Appendix 4C Cash Flow Report
BlinkLab Limited (BB1:AU) has announced Quarterly Activities/Appendix 4C Cash Flow ReportDownload the PDF here. Keep Reading...
31 March
BlinkLab Surpasses Key Milestone in Pivotal U.S. Trial
BlinkLab Limited (BB1:AU) has announced BlinkLab Surpasses Key Milestone in Pivotal U.S. TrialDownload the PDF here. Keep Reading...
30 March
Trading Halt
BlinkLab Limited (BB1:AU) has announced Trading HaltDownload the PDF here. Keep Reading...
26 September
Tech Weekly: Tech Stocks React to Fed, AI News and Geopolitical Tensions
This week’s market action reflected renewed caution amid evolving signals from the US Federal Reserve, with tech stocks facing pressure from shifting interest rate expectations and renewed overvaluation concerns. Artificial intelligence (AI) heavyweight NVIDIA (NASDAQ:NVDA) announced a US$100... Keep Reading...
26 September
Syntheia Signs Definitive Agreement for Call Center Acquisition
Syntheia Corp. (CSE: SYAI) ("Syntheia" or the "Company") (syntheia.ai), today announced that it has entered into an amended and restated agreement dated September 25, 2025 (the "Restated Agreement") with Call Center Guys Inc. ("CCG"), to amend and restate the terms of an asset purchase agreement... Keep Reading...
23 September
NVIDIA Commits US$100 Billion to OpenAI in Landmark AI Infrastructure Push
Semiconductor giant NVIDIA (NASDAQ:NVDA) plans to invest up to US$100 billion in OpenAI to build what executives are calling the largest artificial intelligence (AI) infrastructure project in history.The companies said on Monday (September 22) that OpenAI will deploy NVIDIA's systems on a scale... Keep Reading...
22 September
How to Invest in OpenAI's ChatGPT
OpenAI’s ChatGPT is one of the latest technological breakthroughs in the artificial intelligence space. But what is ChatGPT, and can you invest in OpenAI?This emerging technology is representative of a niche subsector of the AI industry known as generative AI — systems that can generate text,... Keep Reading...
19 September
Tech Weekly: Semiconductor Stocks Rally on Fed Rate Cut and Strategic Deal
The US Federal Reserve lowered its key interest rate for the first time in 2025 this week, while the Bank of Canada resumed cutting after pausing in March, providing a boost to growth-oriented sectors.Tech stocks, particularly semiconductor and artificial intelligence (AI) companies, responded... Keep Reading...
Latest News
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00